目标为零：采用非专利的五药联合多模式方法预防术后恶心呕吐 - Suppr | 超能文献

相似文献

1

Aim for zero: prevention of postoperative nausea and vomiting using an off-patent five-drug multimodal approach.目标为零：采用非专利的五药联合多模式方法预防术后恶心呕吐

Br J Anaesth. 2023 Jul;131(1):e1-e4. doi: 10.1016/j.bja.2023.01.005. Epub 2023 Feb 1.

2

Palonosetron and aprepitant for the prevention of postoperative nausea and vomiting in patients indicated for laparoscopic gynaecologic surgery: a double-blind randomised trial.帕洛诺司琼和阿瑞匹坦预防腹腔镜妇科手术患者术后恶心呕吐的双盲随机试验

BMC Anesthesiol. 2014 Aug 10;14:68. doi: 10.1186/1471-2253-14-68. eCollection 2014.

3

Comparison of palonosetron with palonosetron-dexamethasone combination for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.帕洛诺司琼与帕洛诺司琼-地塞米松联合用药预防腹腔镜胆囊切除术后恶心呕吐的比较。

Minerva Anestesiol. 2014 Jul;80(7):779-84. Epub 2013 Nov 26.

4

Recent advances, trends and economic considerations in the risk assessment, prevention and treatment of postoperative nausea and vomiting.术后恶心呕吐风险评估、预防及治疗的最新进展、趋势与经济考量

Expert Opin Pharmacother. 2007 Dec;8(18):3217-35. doi: 10.1517/14656566.8.18.3217.

5

A randomized double blind study to evaluate efficacy of palonosetron with dexamethasone versus palonosetron alone for prevention of postoperative and postdischarge nausea and vomiting in subjects undergoing laparoscopic surgeries with high emetogenic risk.一项评价帕洛诺司琼联合地塞米松对比单用帕洛诺司琼预防高致吐风险腹腔镜手术患者术后及出院后恶心呕吐的随机双盲研究。

Am J Ther. 2012 Sep;19(5):324-9. doi: 10.1097/MJT.0b013e318209dff1.

6

Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy.帕洛诺司琼联合 3 天阿瑞匹坦和地塞米松预防高致吐性化疗患者的恶心和呕吐。

Support Care Cancer. 2011 Aug;19(8):1159-64. doi: 10.1007/s00520-010-0930-x. Epub 2010 Jun 16.

7

Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy.阿瑞匹坦联合帕洛诺司琼和地塞米松预防接受多日顺铂化疗的患者化疗引起的恶心和呕吐。

Intern Med J. 2013 Jan;43(1):73-6. doi: 10.1111/j.1445-5994.2011.02637.x.

8

Aprepitant, dexamethasone, and palonosetron in the prevention of doxorubicin/cyclophosphamide-induced nausea and vomiting.阿瑞匹坦、地塞米松和帕洛诺司琼预防多柔比星/环磷酰胺所致恶心和呕吐。

Support Care Cancer. 2012 Mar;20(3):653-6. doi: 10.1007/s00520-011-1312-8. Epub 2011 Nov 18.

9

Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients.帕洛诺司琼联合阿瑞匹坦及地塞米松预防尿路上皮癌患者吉西他滨/顺铂化疗引起的恶心和呕吐

Int J Urol. 2015 Oct;22(10):911-4. doi: 10.1111/iju.12842. Epub 2015 Jun 18.

10

Palonosetron, aprepitant, and dexamethasone for prevention of nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: A phase II study.帕洛诺司琼、阿瑞匹坦和地塞米松预防多发性骨髓瘤自体移植中高剂量美法仑后恶心和呕吐的II期研究。

Int J Hematol. 2017 Apr;105(4):478-484. doi: 10.1007/s12185-016-2152-6. Epub 2016 Nov 21.

引用本文的文献

1

Pyridoxine Prevents Postoperative Nausea and Vomiting in Gynecologic Laparoscopic Surgery: A Double-blind Randomized Controlled Trial.吡哆醇预防妇科腹腔镜手术术后恶心和呕吐：一项双盲随机对照试验。

Anesthesiology. 2025 Apr 1;142(4):655-665. doi: 10.1097/ALN.0000000000005354. Epub 2024 Dec 27.

2

Olanzapine as a prophylactic antiemetic for preventing postoperative nausea and vomiting after general anesthesia: A systematic review and meta-analysis.奥氮平作为全麻后预防术后恶心呕吐的预防性止吐药：系统评价和荟萃分析。

Clinics (Sao Paulo). 2024 Mar 20;79:100345. doi: 10.1016/j.clinsp.2024.100345. eCollection 2024.

3